The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain
Abstract
Botulinum toxin type A (BoNT-A) produced by the bacterium Clostridium botulinum is a potent inhibitor of acetylcholine release in the neuromuscular junction and has been used to treat many disorders related to excessive muscle contraction. However, BoNT-A has recently been used in pain therapy to treat myofascial pain, low back pain and various types of headaches, including migraine. The purpose of this study is to investigate the antinociceptive effect of BoNT-A and its underlying mechanism in the rat formalin inflammatory pain model. BoNT-A (3.5, 7, 15 and 30 U/kg) or vehicle was administered to the plantar surface of the right hindpaw of male Sprague-Dawley rats. BoNT-A dose-dependently (P<0.05) inhibited formalin-induced nociceptive behavior during phase 2 but not during phase 1 when administered 5 h to 12 days before formalin challenge. The onset of the antinociceptive effect started at 5 h after pre-treatment and this effect lasted for at least 12 days. BoNT-A (7 U/kg) also reduced edema. Consistent with the lack of effect in the formalin phase 1, BoNT-A, at 15 U/kg, had no effect on acute thermal nociception; no local muscle weakness was observed at this dose. Pre-treatment of rats with BoNT-A (3.5, 7 or 15 U/kg) all significantly reduced formalin-evoked glutamate (Glu) release. These results demonstrate that local peripheral injection of BoNT-A significantly reduces formalin-induced nociceptive behaviors with the absence of obvious muscle weakness. Such an antinociceptive effect of BoNT-A is associated with the inhibition of formalin-induced release of Glu (and/or neuropeptides) from primary afferent terminals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Dubuisson, D., & Dennis, S. G. (1977) · Pain · doi:10.1016/0304-3959(77)90130-0 · Cited by 2,524
The formalin test: an evaluation of the method
Tjølsen, A., Berge, O.-G., Hunskaar, S., Rosland, J. H., & Hole, K. (1992) · Pain · doi:10.1016/0304-3959(92)90003-t · Cited by 2,428
Calcitonin gene-related peptide is a potent vasodilator
Brain, S. D., Williams, T. J., Tippins, J. R., Morris, H. R., & MacIntyre, I. (1985) · Nature · doi:10.1038/313054a0 · Cited by 2,086
Coderre, T. J., Katz, J., Vaccarino, A. L., & Melzack, R. (1993) · Pain · doi:10.1016/0304-3959(93)90161-h · Cited by 1,966 · cited 1×
“The second phase is either the result of sensitization of dorsal horn neurons (central sensitization), inflammation-induced hyperactivity of primary afferent nociceptors, or a combination of both (Coderre et al., 1993; Dickenson and Sullivan, 1987; Tjolsen et al., 1992).”
BackgroundHolzer, P. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90064-4 · Cited by 1,665
Sensory Mechanisms of the Spinal Cord
Willis, W. D., & Coggeshall, R. E. (1978) · Springer eBooks · doi:10.1007/978-1-4757-1688-7 · Cited by 1,456
Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation
Lembeck, F., & Holzer, P. (1979) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00500282 · Cited by 1,198
Activity-dependent neuronal plasticity following tissue injury and inflammation
Dubner, R., & Ruda, M. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90019-5 · Cited by 926
Primary afferent tachykinins are required to experience moderate to intense pain
Cao, Y. Q., Mantyh, P. W., Carlson, E. J., Gillespie, A.-M., Epstein, C. J., & Basbaum, A. I. (1998) · Nature · doi:10.1038/32897 · Cited by 597
De Biasi, S., & Rustioni, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7820 · Cited by 577
Botulinum Toxin Type A as a Migraine Preventive Treatment
Silberstein, S., Mathew, N., Saper, J., Jenkins, S., & for the BOTOX Migraine Clinical Research Group (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00066.x · Cited by 541
Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection
Coderre, T. J., Vaccarino, A. L., & Melzack, R. (1990) · Brain Research · doi:10.1016/0006-8993(90)91835-5 · Cited by 532
Haley, J. E., & Dickenson, A. H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.001 · Cited by 511
Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins
Welch, M. J., Purkiss, J. R., & Foster, K. A. (2000) · Toxicon · doi:10.1016/s0041-0101(99)00153-1 · Cited by 479
Puig, S., & Sorkin, L. S. (1996) · Pain · doi:10.1016/0304-3959(95)00121-2 · Cited by 468
Haley, J. E., Sullivan, A. F., & Dickenson, A. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90975-h · Cited by 460
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
Brin, M. F., Fahn, S., Moskowitz, C., Friedman, A., Shale, H. M., Greene, P. E., Blitzer, A., List, T., Lange, D., Lovelace, R. E., et al. (1987) · Movement Disorders · doi:10.1002/mds.870020402 · Cited by 417
Release of substance P from the cat spinal cord.
Go, V. L., & Yaksh, T. L. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016731 · Cited by 367
The rat paw formalin test: comparison of noxious agents
Wheeler-Aceto, H., Porreca, F., & Cowan, A. (1990) · Pain · doi:10.1016/0304-3959(90)90073-m · Cited by 350
Substance P: Release on trigeminal nerve stimulation, effects in the eye
BILL, A., STJERNSCHANTZ, J., MANDAHL, A., BRODIN, E., & NILSSON, G. (1979) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1979.tb06412.x · Cited by 313
Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat
OTSUKA, M., & KONISHI, S. (1976) · Nature · doi:10.1038/264083a0 · Cited by 287
Dickenson, A. H., & Sullivan, A. F. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90242-4 · Cited by 264
Coggeshall, R. E., & Carlton, S. M. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980202)391:1<78::aid-cne7>3.0.co;2-o · Cited by 246
The primary afferent depolarizing action of kainate in the rat
Agrawal, S. G., & Evans, R. H. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10823.x · Cited by 246
Substance P release from knee joint afferent terminals: modulation by opioids
Yaksh, T. L. (1988) · Brain Research · doi:10.1016/0006-8993(88)90474-x · Cited by 244
Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig
Brimijoin, S., Lundberg, J. M., Brodin, E., Ho¨kfelt, T., & Nilsson, G. (1980) · Brain Research · doi:10.1016/0006-8993(80)91293-7 · Cited by 236
Kuraishi, Y., Hirota, N., Sato, Y., Kaneko, S., Satoh, M., & Takagi, H. (1985) · Brain Research · doi:10.1016/0006-8993(85)91426-x · Cited by 230
Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats
Zhou, S., Bonasera, L., & Carlton, S. M. (1996) · NeuroReport · doi:10.1097/00001756-199603220-00012 · Cited by 228
Inflammation-induced changes in peripheral glutamate receptor populations
Carlton, S. M., & Coggeshall, R. E. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01328-6 · Cited by 216
Glutamate-evoked pain and mechanical allodynia in the human masseter muscle
Svensson, P., Cairns, B. E., Wang, K., Hu, J. W., Graven-Nielsen, T., Arendt-Nielsen, L., & Sessle, B. J. (2003) · Pain · doi:10.1016/s0304-3959(02)00079-9 · Cited by 195
Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw
Omote, K., Kawamata, T., Kawamata, M., & Namiki, A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01568-0 · Cited by 187
Peripheral glutamate release in the hindpaw following low and high intensity sciatic stimulation
deGroot, J., Zhou, S., & Carlton, S. M. (2000) · NeuroReport · doi:10.1097/00001756-200002280-00014 · Cited by 175
Taylor, B., Peterson, M., & Basbaum, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07575.1995 · Cited by 171
Treatment of Chronic Cervical‐Associated Headache With Botulinum Toxin A: A Pilot Study
Freund, B. J., & Schwartz, M. (2000) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00033.x · Cited by 145
White, D. M., & Helme, R. D. (1985) · Brain Research · doi:10.1016/0006-8993(85)90412-3 · Cited by 139
N-methyl-d-aspartate-induced excitation and sensitization of normal and inflamed nociceptors
Du, J., Zhou, S., Coggeshall, R. E., & Carlton, S. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00009-5 · Cited by 135
Poulain, B., Tauc, L., MAISEY, E. A., Wadsworth, J. D. F., Mohan, P., & Dolly, J. O. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4090 · Cited by 116
Tissue concentration and release of substance P‐like immunoreactivity in the dental pulp
Brodin, E., Gazelius, B., Olgart, L. M., & Nilsson, G. (1981) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1981.tb06717.x · Cited by 107
Calcitonin gene-related peptide: Vasoactive effects and potential therapeutic role
Brain, S. D., & Cambridge, H. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00125-5 · Cited by 106
Treatment of tension-type headache with botulinum toxin: a pilot study.
Schulte-Mattler, W. J., Wieser, T., & Zierz, S. (1999) · PubMed · Cited by 90
Botulinum neurotoxin and dendrotoxin as probes for studies on transmitter release.
Dolly, J. O., Halliwell, J. V., Black, J. D., Williams, R. S., Pelchen–Matthews, A., Breeze, A. L., Mehraban, F., Othman, I. B., & Black, A. (1984) · PubMed · Cited by 89
Harmar, A. J., & Keen, P. (1982) · Brain Research · doi:10.1016/0006-8993(82)90374-2 · Cited by 85
Cited by
Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
Ranoux, D., Attal, N., Morain, F., & Bouhassira, D. (2008) · Annals of Neurology · doi:10.1002/ana.21427 · Cited by 459
Apostolidis, A., Dasgupta, P., & Fowler, C. J. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.010 · Cited by 347
Neurogenic inflammation and its role in migraine
Ramachandran, R. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0676-y · Cited by 310
Aurora, S. K., Winner, P., Freeman, M. C., Spierings, E. L., Heiring, J. O., DeGryse, R. E., VanDenburgh, A. M., Nolan, M. E., & Turkel, C. C. (2011) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01990.x · Cited by 295
Vulvodynia: Assessment and Treatment
Goldstein, A. T., Pukall, C. F., Brown, C., Bergeron, S., Stein, A., & Kellogg-Spadt, S. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.01.020 · Cited by 292
Metadata
- Authors
- Cui, M., Khanijou, S., Rubino, J., & Aoki, K. R.
- Venue
- Pain
- Published
- 2004-01
- Volume
- 107
- Issue
- 1
- Pages
- 125-133
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2073224536
- Cited by
- 676
- References
- 43
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.